|
| Press Releases |
|
 |
|
| Tuesday, March 16, 2021 |
|
|
全球第三家天大館落子澳大利亞悉尼 |
| 天大藥業有限公司(香港聯交所主板上市：00455)旗下天大館(集團)有限公司投資興辦的新型中醫館「天大館」，在全球的第三家館 – 悉尼天大館於3月14日上午在悉尼麥覺理園區正式開業。 more info >> |
|
|
The third TDMall in the world opened in Sydney, Australia |
| TDMall (Group) Limited, a subsidiary of Tianda Pharmaceuticals Limited (listed on the main board of the Hong Kong Stock Exchange: 00455) has invested in the establishment of modern-style Chinese medicine clinic - TDMall, and grandly opened its third TDMall in the world, TDMall (Sydney), on 14 March in Macquarie Park, Sydney, Australia. more info >> |
|
| Thursday, March 4, 2021 |
|
|
Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout |
| Tianda Pharmaceuticals Limited (0455.HK) is pleased to announce that its wholly-owned subsidiary, Tianda Pharmaceutical (Zhuhai) Co., Ltd., has entered into a Technology Transfer Contract with Heilongjiang Jiren Pharmaceutical Co., Ltd. to acquire the latter's whole technology ownership and all the intellectual rights in Xiaoer Qingre Zhike Granule, National medicine registration approval number: Z20033093). more info >> |
|
|
天大药业收购小儿清热止咳颗粒剂 丰富产品组合并持续完善中医药全产业链布局 |
| 天大药业有限公司 （「天大药业」，股份代号：455.HK，连同其附属公司称为「本集团」）欣然宣布，其全资附属公司天大药业(珠海)有限公司与黑龙江省济仁药业有限公司订立技术转让合同，以人民币 21,000,000元（相当于约 25,200,000港元）收购其小儿清热止咳颗粒（国药准字Z20033093）的技术完整所有权和全部知识产权。 more info >> |
|
|
天大藥業收購小兒清熱止咳顆粒劑 豐富產品組合並持續完善中醫藥全產業鏈佈局 |
| 天大藥業有限公司 （「天大藥業」，股份代號：455.HK，連同其附屬公司稱為「本集團」）欣然宣佈，其全資附屬公司天大藥業(珠海)有限公司與黑龍江省濟仁藥業有限公司訂立技術轉讓合同，以人民幣 21,000,000元（相當於約 25,200,000港元）收購其小兒清熱止咳顆粒（國藥准字Z20033093）的技術完整所有權和全部知識産權。 more info >> |
|
| Tuesday, October 6, 2020 |
|
|
Tianda Pharmaceuticals acquires Yeung & Young Medicare and Qi's Living, establishing long-term cooperation |
| Tianda Pharmaceuticals Ltd (HKG:0455) is pleased to announce its wholly-owned subsidiary TDMall (Hong Kong) Ltd (TDMall HK) has acquired 50.1% equity interests in both Yeung & Young Medicare Centre Ltd (Yeung & Young) and Qi's Living Company Ltd (Qi's Living), for a total consideration of HK$25 million. more info >> |
|
| Wednesday, October 7, 2020 |
|
|
天大药业收购瑶池医疗及瑶池养生并达成深度合作 |
| 天大药业有限公司 （“天大药业”，股份代号：455.HK，连同其附属公司称为“本集团”）欣然宣布，其全资附属公司天大馆（香港）有限公司（“天大馆香港”）以现金代价2,500万港元收购主要从事中医诊疗的瑶池汉方医疗中心有限公司(“瑶池医疗”) 50.1%权益，及经重组后瑶池汉方旗下主要从事中药保健品销售业务的全资附属公司瑶池汉方养生有限公司(“瑶池养生”)的50.1%权益。 more info >> |
|
|
天大藥業收購瑤池醫療及瑤池養生並達成深度合作 |
| 天大藥業有限公司 （「天大藥業」，股份代號：455.HK，連同其附屬公司稱為「本集團」）欣然宣佈，其全資附屬公司天大館（香港）有限公司（「天大館香港」）以現金代價2,500萬港元收購主要從事中醫診療的瑤池漢方醫療中心有限公司(「瑤池醫療」)50.1%權益，及經重組後瑤池漢方旗下主要從事中藥保健品销售業務的全資附屬公司瑤池漢方養生有限公司(「瑤池養生」)的50.1%權益。 more info >> |
|
| Friday, July 10, 2020 |
|
|
HK Main-Board Listed Tianda Pharmaceuticals (00455.HK) Promising Outlook for Growth |
| With the successive introduction of the "Opinions on Facilitating the Inheritance, Innovation and Development of Traditional Chinese Medicine (TCM)" in certain provinces in mainland China and the "Regulations on Traditional Chinese Medicine" proposed by the Beijing municipality (Drafted Regulations on TCM for Public Opinions), the TCM industry has embarked on a rapid development. more info >> |
|
| Thursday, July 9, 2020 |
|
|
港股主板上市的天大药业（00455.HK）蓄势待发、值得期待 |
| 随着国内各省陆续出台《关于促进中医药传承创新发展的实施意见》、北京市中医药条例（草案公开征求意见稿），中医药行业踏入了快速发展的进程。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AmplifiX Releases Comprehensive Sector Report on the Rapid Acceleration of Real-World Asset (RWA) Tokenization
Jan 22, 2026 12:57: JST
|
|
|
Exito Drives India's Digital-First Revolution with the Flagship 43rd Digital Transformation Summit - India 2026
Jan 22, 2026 12:09: JST
|
|
|
みずほ銀行と富士通、受発注・決済領域における中堅・中小企業向け新サービス創出に向けた企画・開発を開始
Jan 22, 2026 11:30: JST
|
|
|
華營控股榮膺「香港義工獎2025」雙項殊榮 實踐企業責任 共建關愛香港
Jan 22, 2026 11:00 HKT/SGT
|
|
|
AmplifiX Releases Comprehensive Sector Report on the Rapid Acceleration of Real-World Asset (RWA) Tokenization
Jan 21, 2026 23:00 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL TECHNOLOGIES to Exhibit Advanced Precious Metal Materials for Medical Device Components at MD&M West 2026
Jan 21, 2026 22:00 JST
|
|
|
mRNA腫瘤疫苗五年數據印證療效 雲頂新耀搶跑國內個性化腫瘤疫苗賽道
Jan 21, 2026 19:00 HKT/SGT
|
|
|
mRNA肿瘤疫苗五年数据印证疗效 云顶新耀抢跑国内个性化肿瘤疫苗赛道
Jan 21, 2026 19:00 HKT/SGT
|
|
|
Honda to Discontinue Production of Fuel Cell Systems at Fuel Cell System Manufacturing LLC in the U.S.
Jan 21, 2026 17:44 JST
|
|
|
Notice regarding the dissolution of the joint venture in the home elevator business
Jan 21, 2026 17:04 JST
|
|
|
Eisai Listed as a Global 100 Most Sustainable Corporation for the Tenth Time
Jan 21, 2026 16:44 JST
|
|
|
MHI and ITB Deepen Research Collaboration on Ammonia-Based Clean Power in Indonesia
Jan 21, 2026 16:37 JST
|
|
|
Asian Financial Forum opens next Monday with a fresh perspective and new tagline, Finance Empowering Business
Jan 21, 2026 14:30 JST
|
|
|
Exito Drives India's Digital-First Revolution with the Flagship 43rd Digital Transformation Summit - India 2026
Jan 21, 2026 13:00 HKT/SGT
|
|
|
MHI-TCが「自走式舶用旅客搭乗橋」を横浜市に納入、1月13日に供用開始
Jan 21, 2026 11:55: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
